GO:0048008 platelet-derived growth factor receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048008 describes the molecular signaling cascade triggered when a platelet-derived growth factor (PDGF) ligand binds to a PDGF receptor (PDGFR) on the cell surface, culminating in regulation of downstream cellular processes such as transcription.
• The pathway is initiated by PDGF ligands (PDGFA, PDGFB, PDGFC, PDGFD) binding to receptor tyrosine kinases PDGFRA and PDGFRB, leading to receptor dimerization and autophosphorylation.
• Key downstream effectors include PI3K/AKT, PLCγ/PKC, and RAS/MAPK cascades, which control proliferation, migration, survival, and differentiation.
• Dysregulated PDGFR signaling is implicated in cancers (glioma, sarcoma, leukemia), pulmonary arterial hypertension, lung fibrosis, and atherosclerosis.
• Research models for this pathway include knockout mice, point-mutant receptors, knock-in reporters, and overexpression systems, often combined with CRISPR gene editing.
• Studying GO:0048008 requires integrated methods such as phosphoproteomics, live-cell imaging, and CRISPR library screening to dissect causal gene contributions.
Description
The platelet-derived growth factor receptor signaling pathway (GO:0048008) is a fundamental biological process that governs how cells respond to PDGF family ligands. This pathway is initiated when PDGF ligands bind to PDGF receptors (PDGFRs) on the cell surface, triggering a series of intracellular molecular events that ultimately regulate gene transcription and diverse cellular outcomes. As a receptor tyrosine kinase pathway, it plays pivotal roles in embryonic development, tissue repair, and disease pathogenesis. Researchers study GO:0048008 to understand mechanisms of cell proliferation, migration, and survival, and to identify therapeutic targets for cancer, fibrosis, and vascular disorders. The pathway's complexity and broad impact make it a paradigm for signal transduction research.
platelet-derived growth factor receptor signaling pathway At A Glance
| GO ID | GO:0048008 |
|---|---|
| GO term | platelet-derived growth factor receptor signaling pathway |
| Ontology | biological_process |
| Synonym | PDGF receptor signaling pathway; PDGF receptor signalling pathway; PDGFR signaling pathway |
| Major function | Transduces extracellular PDGF signals into cellular responses such as proliferation, migration, and survival |
| Key ligands | PDGFA, PDGFB, PDGFC, PDGFD |
| Key receptors | PDGFRA, PDGFRB |
| Major downstream pathways | PI3K/AKT, PLCγ/PKC, RAS/MAPK |
| Disease relevance | Cancer, pulmonary arterial hypertension, fibrosis, atherosclerosis |
What Is GO:0048008?
GO:0048008, platelet-derived growth factor receptor signaling pathway, is defined as the series of molecular signals initiated by a ligand binding to a platelet-derived growth factor receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. This biological process encompasses ligand-receptor interaction, receptor activation, and downstream signal propagation.
Why Is platelet-derived growth factor receptor signaling pathway Important in Cell Biology?
The platelet-derived growth factor receptor signaling pathway is critically important because it regulates fundamental cellular processes including proliferation, migration, survival, and differentiation, and its dysregulation is a hallmark of numerous human diseases. Understanding this pathway provides insights into developmental biology, tissue homeostasis, and pathological conditions such as cancer and fibrosis, making it a prime target for therapeutic intervention.
• Controls cell proliferation and survival in development and tissue repair.
• Regulates cell migration and actin reorganization during wound healing.
• Implicated in oncogenesis, including gliomas, sarcomas, and leukemias.
• Drives pathological remodeling in pulmonary arterial hypertension.
• Plays a role in lung development and fibrotic diseases.
• Modulates myogenesis and muscle regeneration.
• Serves as a model for receptor tyrosine kinase signaling mechanisms.
• Target for tyrosine kinase inhibitors in cancer therapy.
• Involved in radiation response in high-grade glioma cells.
• Key to understanding cross-talk with other signaling pathways like PI3K/AKT.
What Happens During platelet-derived growth factor receptor signaling pathway?
Ligand Binding and Receptor Dimerization
In simple terms: PDGF ligands bind to PDGF receptors on the cell surface, causing receptors to pair up.
The pathway begins when PDGF ligands (PDGFA, PDGFB, PDGFC, PDGFD) bind to the extracellular domain of PDGF receptors (PDGFRA or PDGFRB), inducing receptor dimerization. This dimerization is essential for activation and brings the intracellular kinase domains into proximity.
Receptor Autophosphorylation and Activation
In simple terms: The paired receptors add phosphate groups to themselves, becoming active.
Upon dimerization, PDGF receptors undergo autophosphorylation on specific tyrosine residues within their intracellular domains. These phosphorylated tyrosines serve as docking sites for SH2 domain-containing signaling proteins, thereby initiating downstream cascades.
Activation of Downstream Signaling Cascades
In simple terms: The activated receptor turns on multiple signaling pathways inside the cell.
Phosphorylated PDGFR recruits and activates several signaling molecules, including PI3K, PLCγ, and the adaptor proteins GRB2/SOS, which activate RAS. PI3K activation leads to AKT phosphorylation, promoting survival and proliferation. PLCγ activation generates IP3 and DAG, leading to PKC activation and calcium release.
Regulation of Transcription and Cellular Responses
In simple terms: Signals travel to the nucleus to change gene expression and cell behavior.
Downstream kinases such as ERK and AKT translocate to the nucleus and regulate transcription factors, leading to changes in gene expression that drive cell cycle progression, migration, and survival. The pathway ultimately regulates processes like proliferation, differentiation, and apoptosis.
Key Genes Involved in GO:0048008 platelet-derived growth factor receptor signaling pathway
The following genes encode core components and regulators of the platelet-derived growth factor receptor signaling pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDGFA | Ligand for PDGF receptors | Implicated in development and cancer |
| PDGFB | Ligand for PDGF receptors | Drives fibrosis and tumor growth |
| PDGFC | Ligand for PDGF receptors | Involved in tissue repair and cancer |
| PDGFD | Ligand for PDGF receptors | Regulates vascular development |
| PDGFRA | Receptor tyrosine kinase | Mutated in gastrointestinal stromal tumors |
| PDGFRB | Receptor tyrosine kinase | Fusion genes in leukemia; target in PAH |
| PIK3CA | PI3K catalytic subunit | Mediates PDGFR-driven AKT signaling |
| PIK3R1 | PI3K regulatory subunit | Modulates PI3K activation |
| AKT1 | Serine/threonine kinase | Key survival effector downstream of PDGFR |
| PLCG1 | Phospholipase C gamma 1 | Mediates PKC and calcium signaling |
| GRB2 | Adaptor protein | Links PDGFR to RAS/MAPK pathway |
| SOS1 | Ras guanine nucleotide exchange factor | Activates RAS downstream of PDGFR |
| HRAS | Small GTPase | Propagates mitogenic signals |
| MAPK1 | Extracellular signal-regulated kinase 2 | Regulates transcription and proliferation |
| MAPK3 | Extracellular signal-regulated kinase 1 | Regulates transcription and proliferation |
| STAT3 | Signal transducer and activator of transcription | Mediates PDGFR-driven gene expression |
| SRC | Non-receptor tyrosine kinase | Modulates PDGFR signaling and cytoskeletal changes |
How Is platelet-derived growth factor receptor signaling pathway Regulated?
The platelet-derived growth factor receptor signaling pathway is tightly regulated at multiple levels. Receptor activation is controlled by ligand availability, receptor dimerization, and autophosphorylation. Negative regulation occurs through phosphatases (e.g., SHP-2), receptor internalization and degradation, and feedback inhibition by downstream effectors such as PKC and AKT. Additionally, cross-talk with other signaling pathways (e.g., integrins, G-protein coupled receptors) modulates pathway output. In disease, loss of regulation leads to sustained activation, contributing to oncogenesis and fibrosis.
platelet-derived growth factor receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDGFRA | Gastrointestinal stromal tumor, glioma | Knockout or point-mutation cell lines |
| PDGFRB | Leukemia, pulmonary arterial hypertension | Knock-in fusion models |
| PDGFB | Fibrosis, atherosclerosis | Overexpression transgenic models |
| PIK3CA | Cancer, overgrowth syndromes | Knockout and point-mutation models |
| AKT1 | Cancer, cell survival | Knockout and overexpression models |
Cancer
Dysregulated PDGFR signaling is a driver in multiple cancers. Activating mutations, gene fusions, and overexpression of PDGFRA or PDGFRB are found in gliomas, gastrointestinal stromal tumors, leukemias, and sarcomas. PDGFR signaling promotes tumor cell proliferation, survival, and angiogenesis, making it a therapeutic target.
Pulmonary Arterial Hypertension (PAH)
In PAH, excessive PDGF signaling contributes to pulmonary vascular remodeling and smooth muscle cell proliferation. PDGFR inhibitors have shown efficacy in preclinical models and are explored clinically.
Fibrotic Diseases
PDGF signaling drives fibroblast proliferation and extracellular matrix deposition in lung fibrosis, liver cirrhosis, and kidney fibrosis. Targeting PDGFR is a strategy to attenuate fibrosis.
Atherosclerosis and Vascular Disease
PDGF promotes smooth muscle cell migration and intimal thickening in atherosclerosis. It also plays a role in restenosis after angioplasty.
From platelet-derived growth factor receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PDGFRA drive tumor proliferation? | PDGFRA knockout cell line |
| What is the effect of a kinase-dead PDGFRB mutation? | Point-mutation knock-in |
| How does PDGFB overexpression affect fibrosis? | Overexpression transgenic mouse |
| Can we track PDGFR signaling in live cells? | Tagged knock-in reporter |
| Which genes modulate PDGFR pathway sensitivity? | CRISPR library screening |
| Does PDGFR inhibition radiosensitize glioma cells? | Knockout + radiation treatment |
How to Study the platelet-derived growth factor receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global tyrosine phosphorylation | Identify PDGFR substrates and effectors |
| Live-cell imaging | Receptor dynamics and localization | Study PDGFR internalization and signaling |
| CRISPR screening | Gene essentiality and modifiers | Discover pathway regulators |
| RNA-seq | Transcriptional changes | Profile PDGF-induced gene expression |
| Western blot | Protein phosphorylation and expression | Validate pathway activation |
| Immunoprecipitation | Protein-protein interactions | Map PDGFR signaling complexes |
| Flow cytometry | Cell surface receptor levels | Quantify PDGFR expression |
| Proliferation assays | Cell growth | Assess functional outcomes |
Phosphoproteomics
Phosphoproteomics enables global profiling of tyrosine phosphorylation events downstream of PDGFR activation, identifying novel effectors and feedback loops.
Live-Cell Imaging
Fluorescently tagged PDGFR and downstream effectors allow real-time visualization of receptor internalization, trafficking, and signaling dynamics.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate PDGFR signaling, revealing synthetic lethal interactions and resistance mechanisms.
Transcriptomics
RNA-seq after PDGF stimulation reveals transcriptional programs controlled by the pathway, providing insights into gene regulation and cellular outcomes.
How CRISPR Can Be Used to Study GO:0048008 platelet-derived growth factor receptor signaling pathway
Knockout
CRISPR knockout of PDGFRA, PDGFRB, or downstream effectors (e.g., PIK3CA, AKT1) ablates pathway activity, enabling studies of loss-of-function phenotypes in proliferation, migration, and survival.
Point Mutation
CRISPR-mediated point mutations can mimic activating or kinase-dead variants of PDGFRs, allowing precise dissection of phosphorylation site functions and drug resistance mechanisms.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous PDGFR loci enables real-time tracking of receptor expression, localization, and interaction dynamics without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of PDGF ligands or receptors can model gain-of-function states observed in cancer and fibrosis, facilitating drug testing.
How EDITGENE Supports platelet-derived growth factor receptor signaling pathway Research
Researchers studying platelet-derived growth factor receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway regulation or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for platelet-derived growth factor receptor signaling pathway research.
Frequently Asked Questions About platelet-derived growth factor receptor signaling pathway
What is the platelet-derived growth factor receptor signaling pathway?
It is the series of molecular signals initiated by PDGF ligand binding to PDGF receptors, leading to regulation of downstream cellular processes such as transcription (GO:0048008).
What genes are involved in platelet-derived growth factor receptor signaling?
Key genes include PDGFA, PDGFB, PDGFC, PDGFD, PDGFRA, PDGFRB, PIK3CA, AKT1, PLCG1, GRB2, and MAPK1/3.
What diseases are associated with PDGFR signaling?
Cancers (glioma, sarcoma, leukemia), pulmonary arterial hypertension, fibrosis, and atherosclerosis.
How is PDGFR signaling regulated?
It is regulated by ligand availability, receptor internalization, phosphatases, and feedback inhibition from downstream kinases.
What are the main downstream pathways of PDGFR?
PI3K/AKT, PLCγ/PKC, and RAS/MAPK cascades.
How can I study PDGFR signaling using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of pathway components.
What is the role of PDGF in cancer?
PDGF signaling drives tumor cell proliferation, survival, and angiogenesis, and is often dysregulated in cancers.
Which cell models are used for PDGFR research?
Common models include fibroblasts, glioma cell lines, vascular smooth muscle cells, and knockout mouse embryonic fibroblasts.
What methods measure PDGFR pathway activity?
Phosphoproteomics, Western blot, live-cell imaging, and RNA-seq are commonly used.
Why is PDGFR a drug target?
Its central role in proliferation and survival makes it a target for tyrosine kinase inhibitors in cancer and fibrosis.
Conclusion
The platelet-derived growth factor receptor signaling pathway (GO:0048008) is a central regulator of cell proliferation, migration, and survival, with profound implications for development and disease. Understanding its molecular mechanisms and regulation is essential for developing targeted therapies. EDITGENE's CRISPR services empower researchers to dissect this pathway with precision, from knockout to knock-in models, accelerating discoveries in cancer, fibrosis, and vascular biology.
References
- 1. Andrae J et al.. 2008. Role of platelet-derived growth factors in physiology and medicine.. Genes Dev 22(10):1276-312 PMID: 18483217
- 2. Fiaschi T et al.. 2003. Down-regulation of platelet-derived growth factor receptor signaling during myogenesis.. Cell Mol Life Sci 60(12):2721-35 PMID: 14685695
- 3. Claesson-Welsh L. 1994. Platelet-derived growth factor receptor signals.. J Biol Chem 269(51):32023-6 PMID: 7798193
- 4. Noskovičová N et al.. 2015. Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies.. Am J Respir Cell Mol Biol 52(3):263-84 PMID: 25303647
- 5. Alexandru O et al.. 2019. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.. Int J Mol Sci 20(19) PMID: 31547056
- 6. Park CS et al.. 2003. Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts.. J Biol Chem 278(39):37064-72 PMID: 12871957
- 7. Berghausen E et al.. 2013. Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension.. Handb Exp Pharmacol 218:381-408 PMID: 24092349
- 8. Yu J et al.. 2003. Platelet-derived growth factor signaling and human cancer.. J Biochem Mol Biol 36(1):49-59 PMID: 12542975
